Full Text
EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA

Abstract

Authors

G Weston Y Yi D Alexander B Serraz C Schad M Fourcroy C Marre

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×